Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned a consensus rating of “Reduce” from the fourteen research firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $134.0833.
CLX has been the topic of a number of research analyst reports. Morgan Stanley decreased their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Barclays dropped their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research report on Tuesday. The Goldman Sachs Group decreased their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, September 8th.
Get Our Latest Research Report on Clorox
Insider Buying and Selling at Clorox
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Total Investment Management Inc. acquired a new stake in shares of Clorox in the second quarter worth $25,000. American National Bank & Trust boosted its position in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares during the period. NewSquare Capital LLC boosted its position in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares during the period. Ransom Advisory Ltd acquired a new stake in Clorox in the 1st quarter valued at $35,000. Finally, Darwin Wealth Management LLC purchased a new position in Clorox in the second quarter valued at about $29,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Clorox Stock Up 0.9%
CLX stock opened at $123.30 on Friday. The company has a 50 day moving average price of $122.81 and a two-hundred day moving average price of $129.64. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a market capitalization of $15.08 billion, a P/E ratio of 18.91, a PEG ratio of 0.98 and a beta of 0.52. Clorox has a one year low of $116.53 and a one year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts expect that Clorox will post 7.15 EPS for the current year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox’s dividend payout ratio is currently 76.07%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Technology Stocks Explained: Here’s What to Know About Tech
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- How to Invest in Insurance Companies: A Guide
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Insider Buying Explained: What Investors Need to Know
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
